Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Arpita Pal, Sudeep Roy, Akhil Kumar, Syed Mahmood, Nasrin Khodapanah, Christian Agatemor, Kajal Ghosal
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The Role of Glimepiride in the Effective Management of Type 2 Diabetes
10.1016/j.jdiacomp.2004.07.001 · 2004
Solubility Enhancement Strategies for Poorly Water-Soluble Drugs in Solid Dispersions: A Review
2016
Pharmaceutical Particle Technologies: An Approach to Improve Drug Solubility, Dissolution and Bioavailability
10.1016/j.ajps.2014.05.005 · 2014
Cyclodextrin-Based Pharmaceutics: Past, Present and Future
10.1038/nrd1576 · 2004
Physicochemical Characterization and Dissolution of Norfloxacin/Cyclodextrin Inclusion Compounds and PEG Solid Dispersions
10.1016/0378-5173(95)00039-l · 1995
Similar Modes of Inclusion in Complexes of β-Cyclodextrin with Sulfonylurea Hypoglycemic Drugs
10.1039/b908128c · 2010
Effectiveness of Mechanochemical Treatment with Cyclodextrins on Increasing Solubility of Glimepiride
10.1691/ph.2009.9045 · 2009
Formulation and Biological Evaluation of Glimepiride–Cyclodextrin–Polymer Systems
10.1016/j.ijpharm.2005.11.024 · 2006
Inclusion Complexation of Glimepiride in Dimethyl-β-Cyclodextrin
2007
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
Implication of Inclusion Complexation of Glimepiride in Cyclodextrin–Polymer Systems on Its Dissolution, Stability and Therapeutic Efficacy
10.1016/j.ijpharm.2006.04.002 · 2006
Combined Use of Cyclodextrins and Hydroxypropylmethylcellulose Stearoxy Ether (Sangelose®) for the Preparation of Orally Disintegrating Tablets of Type-2 Antidiabetes Agent Glimepiride
10.1007/s10847-014-0386-6 · 2014
Comparative Interaction of 2-Hydroxypropyl-β-Cyclodextrin and Sulfobutylether-β-Cyclodextrin with Itraconazole: Phase-Solubility Behavior and Stabilization of Supersaturated Drug Solutions
10.1016/j.ejps.2008.02.007 · 2008
Improved Aqueous Solubility of Crystalline Astaxanthin (3, 3′-dihydroxy-β, Β-carotene-4, 4′-dione) by Captisol®(Sulfobutyl Ether Β-cyclodextrin)
10.1002/jps.10359 · 2003
Preclinical Studies of a Kidney Safe Iodinated Contrast Agent
10.1111/jon.12356 · 2016
Physicochemical Characterization and in Vitro Dissolution Performance of Ibuprofen-Captisol®(Sulfobutylether Sodium Salt of β-CD) Inclusion Complexes
10.1016/j.molliq.2018.04.007 · 2018
Solution Stability of Captisol-Stabilized Melphalan (Evomela) versus Propylene Glycol-Based Melphalan Hydrochloride Injection
10.1080/10837450.2016.1265557 · 2018
Influence of Sulfobutyl Ether β-Cyclodextrin (Captisol®) on the Dissolution Properties of a Poorly Soluble Drug from Extrudates Prepared by Hot-Melt Extrusion
10.1016/j.ijpharm.2007.08.038 · 2008
The Use of Captisol (SBE7-β-CD) in Oral Solubility-Enabling Formulations: Comparison to HPβCD and the Solubility–Permeability Interplay
10.1016/j.ejps.2015.05.024 · 2015
Structural Characterization of N-Protonated Amides: Regioselective N-Activation of Medium-Bridged Twisted Lactams
10.1021/ja101690u · 2010
Effect of Acid, Base and Time on Different Brands of Glimepiride
2014
Temperature, Stability, and the Hydrophobic Interaction
10.1016/s0006-3495(97)78324-3 · 1997
A Phase Solubility Technique
1965
Cyclodextrins and Ternary Complexes: Technology to Improve Solubility of Poorly Soluble Drugs
10.1590/s1984-82502011000400003 · 2011
Influence of the Preparation Method on the Physicochemical Properties of Ketoprofen–Cyclodextrin Binary Systems
10.1016/s0378-5173(98)00390-1 · 1999
Can Entropy and “Order” Increase Together?
10.1016/0375-9601(84)90934-4 · 1984
Role of Cyclodextrins in Improving Oral Drug Delivery
10.2165/00137696-200402040-00006 · 2004
Analysis of Steady State and Non-Steady State Corneal Permeation of Diclofenac
10.1039/c6ra03604j · 2016
G_mmpbsa A GROMACS Tool for High-Throughput MM-PBSA Calculations
10.1021/ci500020m · 2014
A Characterization Study of Resveratrol/Sulfobutyl Ether-β-Cyclodextrin Inclusion Complex and in Vitro Anticancer Activity
10.1016/j.colsurfb.2013.11.025 · 2014
Novel Pimozide-β-Cyclodextrin-Polyvinylpyrrolidone Inclusion Complexes for Tourette Syndrome Treatment
10.1016/j.molliq.2015.12.054 · 2016
Enhanced Oral Bioavailability of Acyclovir by Inclusion Complex Using Hydroxypropyl-β-Cyclodextrin
10.3109/10717544.2013.853213 · 2014
Inclusion Complexes of Tadalafil with Natural and Chemically Modified β-Cyclodextrins I: Preparation and in-Vitro Evaluation
10.1016/j.ejpb.2008.06.024 · 2008
Surface Solid Dispersion of Glimepiride for Enhancement of Dissolution Rate
2009
Ternary Complexation of Carvedilol, β-Cyclodextrin and Citric Acid for Mouth-Dissolving Tablet Formulation
10.2478/v10007-009-0001-3 · 2009
Cyclodextrins as Functional Excipients: Methods to Enhance Complexation Efficiency
10.1002/jps.23077 · 2012
GROMACS: A Message-Passing Parallel Molecular Dynamics Implementation
10.1016/0010-4655(95)00042-e · 1995
GROMACS 3.0: A Package for Molecular Simulation and Trajectory Analysis
10.1007/s008940100045 · 2001
Comparison of three molecular simulation approaches for cyclodextrin-ibuprofen complexation
10.1155/2015/193049 · 2015
Preperation And Characterization Of Β-Cyclodextrin Inclusion Complexes Oral Tablets Containing Poorly Water Soluble Glimipiride Using Freeze Drying Method
10.14499/indonesianjpharm26iss2pp71 · 2015
What Is a Suitable Dissolution Method for Drug Nanoparticles?
10.1007/s11095-008-9560-0 · 2008
No additional external references are available.